• Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


26.106 EUR 0.401 1.56%

As of 02:14:09 ET on 11/28/2014.

Snapshot for Merck KGaA (MRKA)

Open: 26.106 Day's Range: 26.106 - 26.106 Volume: 0
Previous Close: 25.705 52wk Range: 10.283 - 26.513 1-Yr Rtn: +27.84%

Stock Chart for MRKA

No chart data available.
  • MRKA:GR 26.106
  • 1M
  • 1Y
Interactive MRKA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MRKA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 5.4730
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 4.7700
Est. PEG Ratio 0.9276
Market Cap (M EUR) 34,050.93
Shares Outstanding (M) 387.73
30 Day Average Volume 79
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.20%
Cash Dividend (USD) 0.2956
Dividend Ex-Date 05/07/2014
5 Year Dividend Growth -
Next Earnings Announcement 03/03/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MRKA

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for MRKA

Merck KGaA is a global pharmaceutical and chemicals company. The Company researches drugs in the areas oncology and neurodegenerative as well as autoimmune and inflammatory diseases. Also, it markets cardiovascular, fertility, endocrinology, and over-the-counter products as well as products for flat screens and the pharmaceutical, food, cosmetics, packaging, and coatings.

Karl-Ludwig KleyChairman-Mgmt Board/CEOMarcus KuhnertCFO/Member-Exec Board
Kai BeckmannChief Administration OfficerBernd ReckmannCEO:Chemicals
More Company Profile & Key Executives for MRKA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil